Learn languages naturally with fresh, real content!

Popular Topics
Explore By Region
Novo Nordisk plans to cut 9,000 jobs globally to focus on obesity and diabetes treatments.
Danish pharmaceutical company Novo Nordisk plans to cut 9,000 jobs globally, including 5,000 in Denmark, to streamline operations and boost focus on obesity and diabetes treatments amid increased market competition.
The restructuring aims to save $1.25 billion by 2026, which will be redirected to research and development in growth areas.
The move follows slowing sales growth and intense competition, particularly from Eli Lilly.
42 Articles
Novo Nordisk planea recortar 9.000 empleos en todo el mundo para centrarse en los tratamientos de la obesidad y la diabetes.